Pharmacological Potential of Advance Diabetes Support Product in the Management of Insulin-Dependent Diabetes: Overviews on Case Study
Q: Is the topic relevant to the journal's area of interest? Is it contemporary and interesting for
Abstract & Keywords
Q: Are all required components included in the abstract? Are the keywords appropriately chosen?
Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?
Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?
Tools and Methods
Q: Are the methods the author uses adequate and well used?
Discussion & Conclusion
Q: Is it related to the results presented before? Do you consider them coherent?
Comments: The Discussion gives an outline of Diabetes Mellitus and its occurrence worldwide among the population, followed by the treatment methods. It also discusses the disadvantages of insulin therapy and the need for the development of herbal formulations that will enhance sustained glycemic control and reduce insulin resistance and hypoglycemia in individuals with diabetes mellitus. The Conclusion highlights the promising results of the advance diabetic support product with its evidence to further use as a monotherapy or adjunctive therapy.
Q: Does the author utilize relevant literature?
Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?
Q: Is the paper's length adequate to the topic's significance? Do you suggest shortening the paper without losing its value?
Figures & Tables
Q: Does the author use them suitably? Are legend and notations clear?
Q: Is it clear and understandable?
Further comments on the paper
Comments: The manuscript provides an overview of the current understanding of the pharmacological potential of advance diabetes support product management of insulin-dependent diabetes. It further illustrates the overall methodology, treatment, statistical analysis and results of the study. The study suggests that the advance diabetes support product should be further extensively used as a monotherapy or adjunctive therapy for the regulation, management or control of insulin-dependent diabetes.
Q: Would you recommend this manuscript for further publication?
A: Yes - Suitable to be published
If you have any questions and clarifications you can write to the journal.
Science Repository Team
This email is restricted to the intended user.
|Science Repository - Support|
Corresponding AuthorDheeraj Nagore
Mprex Healthcare P. Ltd, Wakad, Pune, India
Article TypeResearch Article
Publication historyReceived: Mon 01, Aug 2022
Accepted: Tue 16, Aug 2022
Published: Fri 16, Sep 2022
Copyright© 2023 Dheeraj Nagore. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.